Sponsor Profile
Mission Statement
We are leading a revolution in oncology to redefine cancer care. We have a bold ambition to provide cures for cancer in every form. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save lives of people around the world.
Our Efforts Concerning Pancreatic Cancer
We are following the science to understand the complexities of this aggressive cancer and the role of genetic mutations in the development and treatment of pancreatic cancer that has spread to other parts of the body – such as mutations in the BRCA1 or BRCA2 gene. As we aim to revolutionize the treatment of pancreatic cancer, we work to empower patients and their families to have informed conversations with their doctor about their care.
Ways We Support WPCC
As part of our commitment to redefining cancer care, we proudly partner with organizations like WPCC to advocate for patients with pancreatic cancer and educate on this disease.
Mission Statement
Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We are committed to discovering new treatments in areas with high unmet medical needs and improving patients lives.
Our Efforts Concerning Pancreatic Cancer
At Ipsen, we work with patients, for patients, to help deliver outcomes that matter to them. Ipsen is committed to improving patient lives, and to us, every patient matters. We are emboldened and inspired by them and work to support patients with pancreatic cancer.
Ways We Support WPCC
At Ipsen, working with patient organizations is essential to have a deep understanding of what matters most. Ipsen’s mission is to prolong and improve patients’ lives and health outcomes. This year, we look forward to increasing awareness for one of the toughest cancers by participating in the World Pancreatic Cancer Day Campaign and the Annual Meeting.
Mission Statement
Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.
Our Efforts Concerning Pancreatic Cancer
Ways We Support WPCC
Mission Statement
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
Our Efforts Concerning Pancreatic Cancer
At Novocure, together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by supporting patients on our therapy called Tumor Treating Fields and by advancing our clinical trial efforts. To learn more about the PANOVA-3 clinical trial, please visit www.novocuretrial.com/panova.
Ways We Support WPCC
We aspire to make a difference in cancer from day one. Our team stands alongside patients, their families, caregivers and advocacy organizations around the world in their dedication to re-define living with cancer. Collectively with other leaders in pancreatic cancer, we have the opportunity to raise global awareness of this disease and aim to save more lives. Together, we are stronger. Novocure is proud to support the World Pancreatic Cancer Coalition.
Mission Statement
We are leading a revolution in oncology to redefine cancer care. We have a bold ambition to provide cures for cancer in every form. We are following the science to understand cancer and all its complexities to discover, develop and deliver life-changing treatments and increase the potential to save lives of people around the world.
Our Efforts Concerning Pancreatic Cancer
We are following the science to understand the complexities of this aggressive cancer and the role of genetic mutations in the development and treatment of pancreatic cancer that has spread to other parts of the body – such as mutations in the BRCA1 or BRCA2 gene. As we aim to revolutionize the treatment of pancreatic cancer, we work to empower patients and their families to have informed conversations with their doctor about their care.
Ways We Support WPCC
As part of our commitment to redefining cancer care, we proudly partner with organizations like WPCC to advocate for patients with pancreatic cancer and educate on this disease.
Mission Statement
Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We are committed to discovering new treatments in areas with high unmet medical needs and improving patients lives.
Our Efforts Concerning Pancreatic Cancer
At Ipsen, we work with patients, for patients, to help deliver outcomes that matter to them. Ipsen is committed to improving patient lives, and to us, every patient matters. We are emboldened and inspired by them and work to support patients with pancreatic cancer.
Ways We Support WPCC
At Ipsen, working with patient organizations is essential to have a deep understanding of what matters most. Ipsen’s mission is to prolong and improve patients’ lives and health outcomes. This year, we look forward to increasing awareness for one of the toughest cancers by participating in the World Pancreatic Cancer Day Campaign and the Annual Meeting.
Mission Statement
Immunovia Inc.’s goals are to empower patients to understand their familial or hereditary risk for developing pancreatic cancer, and to provide access to the IMMray PanCan-d test, a non-invasive, accurate blood test for the early detection of pancreatic ductal adenocarcinoma in individuals at high risk for familial or hereditary pancreatic cancer.
Our Efforts Concerning Pancreatic Cancer
Immunovia developed the platform for the IMMray PanCan-d test, a blood test for the early detection of pancreatic ductal adenocarcinoma (PDAC) in individuals at high-risk for developing familial or hereditary pancreatic cancer. A recent study demonstrated the IMMray PanCan-d test could detect stage I & II PDAC with 89% sensitivity and stages I-IV PDAC with 92% sensitivity, with 99% specificity. The IMMray PanCan-d test is now available exclusively through the Immunovia, Inc. laboratory in Marlborough, MA.
Ways We Support WPCC
For global collaboration, and to raise awareness of pancreatic cancer and its risk factors, with the ultimate goal of increasing early detection.
Mission Statement
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
Our Efforts Concerning Pancreatic Cancer
At Novocure, together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by supporting patients on our therapy called Tumor Treating Fields and by advancing our clinical trial efforts. To learn more about the PANOVA-3 clinical trial, please visit www.novocuretrial.com/panova.
Ways We Support WPCC
We aspire to make a difference in cancer from day one. Our team stands alongside patients, their families, caregivers and advocacy organizations around the world in their dedication to re-define living with cancer. Collectively with other leaders in pancreatic cancer, we have the opportunity to raise global awareness of this disease and aim to save more lives. Together, we are stronger. Novocure is proud to support the World Pancreatic Cancer Coalition.
Become a Sponsor
If you are interested in learning more about sponsorship
opportunities with the World Pancreatic Cancer Coalition,
please contact us.
[fts_instagram instagram_id=17841401483673998 access_token=IGQVJWTGJUbjdrU0VqVkRkSEEtVE5fNFRTMzNzYmdoTU5iQXprSFgwNDlySVFfeVBNa0JOamZA0RkFkOV9hY1lJMkxtOGtYeWlNTWY4TTdrbElENlc2UVF5QXlyNFJ6NkFxUTY2S3N3 pics_count=5 type=basic width=100% height=100% super_gallery=yes columns=6 force_columns=no space_between_photos=1px icon_size=65px hide_date_likes_comments=no]
